For many biomedical innovators, design controls can feel like a maze of regulations standing between breakthrough ideas and real-world impact. But what if they’re not a barrier, but a blueprint? From idea to creating a startup to commercialization of the device, flexible/scalable Design Controls can drive patient confidence and engineering excellence while meeting regulatory requirements.  Jason Glithero has over 20 years of medical device experience in using and upgrading design control systems that lead to agile and faster design development scenarios. This session will help you rethink compliance as a strategic advantage.

Register to attend via Zoom.

The Bench2Market funding series is created to provide commercialization guidance to the university research community. Learn more at https://biolocity.gatech.edu/news-and-events/b2m-talks/.